Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sonja Bergmann, Anja Coym, Leonie Ott, Armin Soave, Michael Rink, Melanie Janning, Malgorzata Stoupiec, Cornelia Coith, Sven Peine, Gunhild von Amsberg, Klaus Pantel & Sabine Riethdorf. (2020) Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC). OncoImmunology 9:1.
Read now
Read now
Articles from other publishers (58)
Jinghan Yang, Liang Qiu, Xi Wang, Xi Chen, Pingdong Cao, Zhe Yang & Qiang Wen. (2023) Liquid biopsy biomarkers to guide immunotherapy in breast cancer. Frontiers in Immunology 14.
Crossref
Crossref
Sikiru O. Imodoye & Kamoru A. Adedokun. (2023) EMT-induced immune evasion: connecting the dots from mechanisms to therapy. Clinical and Experimental Medicine.
Crossref
Crossref
Kalliopi Andrikou, Tania Rossi, Alberto Verlicchi, Ilaria Priano, Paola Cravero, Marco Angelo Burgio, Lucio Crinò, Sara Bandini, Paola Ulivi & Angelo Delmonte. (2023) Circulating Tumour Cells: Detection and Application in Advanced Non-Small Cell Lung Cancer. International Journal of Molecular Sciences 24:22, pages 16085.
Crossref
Crossref
Chiara Nicolazzo, Federica Francescangeli, Valentina Magri, Alessandro Giuliani, Ann Zeuner & Paola Gazzaniga. (2023) Is cancer an intelligent species?. Cancer and Metastasis Reviews.
Crossref
Crossref
Sara V. Ochoa, Zulma Casas, Sonia L. Albarracín, Jhon Jairo Sutachan & Yolima P. Torres. (2023) Therapeutic potential of TRPM8 channels in cancer treatment. Frontiers in Pharmacology 14.
Crossref
Crossref
Mark Bates, Bashir M. Mohamed, Mark P. Ward, Tanya E. Kelly, Roisin O’Connor, Victoria Malone, Robert Brooks, Doug Brooks, Stavros Selemidis, Cara Martin, Sharon O’Toole & John J. O’Leary. (2023) Circulating tumour cells: The Good, the Bad and the Ugly. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:2, pages 188863.
Crossref
Crossref
Antonino Belfiore, Rosaria Valentina Rapicavoli, Rosario Le Moli, Rosamaria Lappano, Andrea Morrione, Ernestina Marianna De Francesco & Veronica Vella. (2023) IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?. Biomedicines 11:1, pages 229.
Crossref
Crossref
Radu Pirlog, Paul Chiroi, Lajos Raduly, Andreea Nutu, Andrei Cismaru & Ioana Berindan-Neagoe. 2023.
Benjamin Genenger, Jay R. Perry, Bruce Ashford & Marie Ranson. (2022) A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review). Discover Oncology 13:1.
Crossref
Crossref
Ákos Gasparics & Attila Sebe. (2022) Forward Genetic Screens as Tools to Investigate Role and Mechanisms of EMT in Cancer. Cancers 14:23, pages 5928.
Crossref
Crossref
Xuewen Deng & Hiroshi Terunuma. (2022) Harnessing NK Cells to Control Metastasis. Vaccines 10:12, pages 2018.
Crossref
Crossref
Thareeya Phetphoung, Ashwini Malla, Kaewta Rattanapisit, Nuttapat Pisuttinusart, Naruechai Damrongyot, Keerati Joyjamras, Pithi Chanvorachote, Tanapati Phakham, Tossapon Wongtangprasert, Richard Strasser, Chatchai Chaotham & Waranyoo Phoolcharoen. (2022) Expression of plant-produced anti-PD-L1 antibody with anoikis sensitizing activity in human lung cancer cells via., suppression on epithelial-mesenchymal transition. PLOS ONE 17:11, pages e0274737.
Crossref
Crossref
Jianxin Tao, Lei Zhu, Mina Yakoub, Christoph Reißfelder, Sonja Loges & Sebastian Schölch. (2022) Cell–Cell Interactions Drive Metastasis of Circulating Tumor Microemboli. Cancer Research 82:15, pages 2661-2671.
Crossref
Crossref
Shufang Yan, Qinyu Shang, Haipeng Zhu, Ken Chen, Xinxia Li, Hongliang Gao, Bo Liu, Mei Feng & Lixia Gao. (2022) Effects of hsa-miR-28-5p on Adriamycin Sensitivity in Diffuse Large B-Cell Lymphoma. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Crossref
Riley D.Z. Mullins, Ananya Pal, Thomas F. Barrett, Molly E. Heft Neal & Sidharth V. Puram. (2022) Epithelial–Mesenchymal Plasticity in Tumor Immune Evasion. Cancer Research 82:13, pages 2329-2343.
Crossref
Crossref
Rui Bai, Jianguo Zhang, Fajian He, Yangyi Li, Panpan Dai, Zhengrong Huang, Linzhi Han, Zhihao Wang, Yan Gong & Conghua Xie. (2022) GPR87 promotes tumor cell invasion and mediates the immunogenomic landscape of lung adenocarcinoma. Communications Biology 5:1.
Crossref
Crossref
Tao Wang, Desirée Denman, Silvia M. Bacot & Gerald M. Feldman. (2022) Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy. Biomedicines 10:5, pages 1181.
Crossref
Crossref
J. Chen, Y. Liu, Y. Zhu, Y. Chen, J. Feng, T. Jiang, X. Zheng, L. Chen & J. Jiang. (2022) STAT1/IFIT2 signaling pathway is involved in PD-L1-mediated epithelial-to-mesenchymal transition in human esophageal cancer. Clinical and Translational Oncology 24:5, pages 927-940.
Crossref
Crossref
Joanna Kapeleris, Majid Ebrahimi Warkiani, Arutha Kulasinghe, Ian Vela, Liz Kenny, Rahul Ladwa, Kenneth O’Byrne & Chamindie Punyadeera. (2022) Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update. Frontiers in Oncology 12.
Crossref
Crossref
Wen-Ming Wang, Hua Shen, Zi-Ning Liu, Yuan-Yuan Chen, Li-Jun Hou & Yi Ding. (2022) Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression. Cancer Treatment and Research Communications 32, pages 100592.
Crossref
Crossref
Federica Francescangeli, Valentina Magri, Maria Laura De Angelis, Gianluigi De Renzi, Orietta Gandini, Ann Zeuner, Paola Gazzaniga & Chiara Nicolazzo. (2021) Sequential Isolation and Characterization of Single CTCs and Large CTC Clusters in Metastatic Colorectal Cancer Patients. Cancers 13:24, pages 6362.
Crossref
Crossref
Sara Bravaccini, Giuseppe Bronte, Elisabetta Petracci, Maurizio Puccetti, Manolo D’Arcangelo, Sara Ravaioli, Maria Maddalena Tumedei, Roberta Maltoni, Angelo Delmonte, Federico Cappuzzo & Lucio Crinò. (2021) The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Zdeněk Kejík, Robert Kaplánek, Petr Dytrych, Michal Masařík, Kateřina Veselá, Nikita Abramenko, David Hoskovec, Martina Vašáková, Jarmila Králová, Pavel Martásek & Milan Jakubek. (2021) Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design. Pharmaceutics 13:11, pages 1879.
Crossref
Crossref
Tiantian Wu, Caijin Tang, Renchuan Tao, Xiangzhi Yong, Qiaozhi Jiang & Cong Feng. (2021) PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers. Frontiers in Immunology 12.
Crossref
Crossref
Yi-Min Gu, Yue Zhuo, Long-Qi Chen & Yong Yuan. (2021) The Clinical Application of Neoantigens in Esophageal Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Javier De Las Rivas, Anamaria Brozovic, Sivan Izraely, Alba Casas-Pais, Isaac P. Witz & Angélica Figueroa. (2021) Cancer drug resistance induced by EMT: novel therapeutic strategies. Archives of Toxicology 95:7, pages 2279-2297.
Crossref
Crossref
Laura Bornes, Guillaume Belthier & Jacco van Rheenen. (2021) Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States. Journal of Clinical Medicine 10:11, pages 2403.
Crossref
Crossref
Giuseppe Bronte, Maurizio Puccetti, Elisabetta Petracci, Lorenza Landi, Paola Cravero, Simona Scodes, Paola Ulivi, Sara Ravaioli, Maria Maddalena Tumedei, Marco Angelo Burgio, Federico Cappuzzo, Angelo Delmonte, Lucio Crinò & Sara Bravaccini. (2021) The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer. Frontiers in Oncology 11.
Crossref
Crossref
Toshi Menju & Hiroshi Date. (2021) Lung cancer and epithelial-mesenchymal transition. General Thoracic and Cardiovascular Surgery 69:5, pages 781-789.
Crossref
Crossref
Evangelia Pantazaka, Vasileios Vardas, Argyro Roumeliotou, Stavros Kakavogiannis & Galatea Kallergi. (2021) Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients. Cancers 13:9, pages 2158.
Crossref
Crossref
Chunhua Chen, Shiheng Li, Junli Xue, Manlong Qi, Xin Liu, Yan Huang, Jinghua Hu, Haidong Dong & Kun Ling. (2021) PD-L1 tumor-intrinsic signaling and its therapeutic implication in triple-negative breast cancer. JCI Insight 6:8.
Crossref
Crossref
Vaishali Aggarwal, Catalina Ardila Montoya, Vera S. Donnenberg & Shilpa Sant. (2021) Interplay between tumor microenvironment and partial EMT as the driver of tumor progression. iScience 24:2, pages 102113.
Crossref
Crossref
Fabrizio Marcucci & Cristiano Rumio. (2020) The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?. Cellular and Molecular Life Sciences 78:3, pages 853-865.
Crossref
Crossref
Aliki Ntzifa, Areti Strati, Galatea Kallergi, Athanasios Kotsakis, Vassilis Georgoulias & Evi Lianidou. (2021) Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients. Scientific Reports 11:1.
Crossref
Crossref
Hara Polioudaki, Anastasia Mala, Eleni Gkimprixi, Maria Papadaki, Amanda Chantziou, Maria Tzardi, Dimitris Mavroudis, Sofia Agelaki & Panayiotis Theodoropoulos. (2020) Epithelial/Mesenchymal Characteristics and PD-L1 Co-Expression in CTCs of Metastatic Breast Cancer Patients Treated with Eribulin: Correlation with Clinical Outcome. Cancers 12:12, pages 3735.
Crossref
Crossref
Takahiro Okabe, Shinsaku Togo, Yuichi Fujimoto, Junko Watanabe, Issei Sumiyoshi, Akira Orimo & Kazuhisa Takahashi. (2020) Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy. Cancers 12:12, pages 3588.
Crossref
Crossref
Lucrezia Raimondi, Filippo Maria Raimondi, Laura Di Benedetto, Giuseppe Cimino & Gian Paolo Spinelli. (2020) PD-L1 Expression on Circulating Tumour Cells May Be Predictive of Response to Regorafenib in Patients Diagnosed with Chemorefractory Metastatic Colorectal Cancer. International Journal of Molecular Sciences 21:18, pages 6907.
Crossref
Crossref
Anthony Genna, Aline M. Vanwynsberghe, Amélie V. Villard, Charles Pottier, Julien Ancel, Myriam Polette & Christine Gilles. (2020) EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers 12:6, pages 1632.
Crossref
Crossref
Magdalena Zajac, Jiabu Ye, Pralay Mukhopadhyay, Xiaoping Jin, Yong Ben, Joyce Antal, Ashok K. Gupta, Marlon C. Rebelatto, J. Andrew Williams & Jill Walker. (2020) Optimal PD-L1–high cutoff for association with overall survival in patients with urothelial cancer treated with durvalumab monotherapy. PLOS ONE 15:4, pages e0231936.
Crossref
Crossref
Shunichi Sudo, Hiroshi Kajiya, Shinji Okano, Mina Sasaki, Yuri Katsumata, Jun Ohno, Tetsuro Ikebe, Akimitsu Hiraki & Koji Okabe. (2020) Cisplatin‐induced programmed cell death ligand‐2 expression is associated with metastasis ability in oral squamous cell carcinoma. Cancer Science 111:4, pages 1113-1123.
Crossref
Crossref
Meysam Yousefi, Parisa Ghaffari, Rahim Nosrati, Sadegh Dehghani, Arash Salmaninejad, Yousef Jafari Abarghan & Seyed H. Ghaffari. (2019) Prognostic and therapeutic significance of circulating tumor cells in patients with lung cancer. Cellular Oncology 43:1, pages 31-49.
Crossref
Crossref
Shana O Kelley & Klaus Pantel. (2020) A New Era in Liquid Biopsy: From Genotype to Phenotype. Clinical Chemistry 66:1, pages 89-96.
Crossref
Crossref
Menno Tamminga, Sanne de Wit, T. Jeroen N. Hiltermann, Wim Timens, Ed Schuuring, Leon W. M. M. Terstappen & Harry J. M. Groen. (2019) Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Yuan Cheng, Lei Luo, Juqiang Zhang, Mantian Zhou, Yujun Tang, Guolin He, Yishi Lu, Zhong Wang & MingXin Pan. (2019) Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 23:12, pages 2354-2361.
Crossref
Crossref
de Miguel-Pérez, Bayarri-Lara, Ortega, Russo, Moyano Rodriguez, Alvarez-Cubero, Maza Serrano, Lorente, Rolfo & Serrano. (2019) Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma. Cancers 11:11, pages 1750.
Crossref
Crossref
Ziming Li, Zhuo Wang, Yin Tang, Xiang Lu, Jie Chen, Yu Dong, Baojun Wu, Chunying Wang, Liu Yang, Zhili Guo, Min Xue, Shun Lu, Wei Wei & Qihui Shi. (2019) Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics. Nature Communications 10:1.
Crossref
Crossref
Kloten, Lampignano, Krahn & Schlange. (2019) Circulating Tumor Cell PD-L1 Expression as Biomarker for Therapeutic Efficacy of Immune Checkpoint Inhibition in NSCLC. Cells 8:8, pages 809.
Crossref
Crossref
Melanie Janning, Franca Kobus, Anna Babayan, Harriet Wikman, Janna-Lisa Velthaus, Sonja Bergmann, Stefanie Schatz, Markus Falk, Lars-Arne Berger, Lisa-Marie Böttcher, Sarina Päsler, Tobias M. Gorges, Linda O’Flaherty, Claudia Hille, Simon A. Joosse, Ronald Simon, Markus Tiemann, Carsten Bokemeyer, Martin Reck, Sabine Riethdorf, Klaus Pantel & Sonja Loges. (2019) Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors. Cancers 11:6, pages 835.
Crossref
Crossref
Yariswamy Manjunath, Sathisha V. Upparahalli, Diego M. Avella, Chelsea B. Deroche, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, Charles J. Smith, Guangfu Li & Jussuf T. Kaifi. (2019) PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer. Cancers 11:6, pages 806.
Crossref
Crossref
Jingya Zhao, Mingxiang Feng, Dong Liu, Haixia Liu, Mengmeng Shi, Jing Zhang & Jieming Qu. (2019) Antagonism between HTRA3 and TGFβ1 Contributes to Metastasis in Non–Small Cell Lung Cancer. Cancer Research 79:11, pages 2853-2864.
Crossref
Crossref
Patricia G. Santamaría, Gema Moreno-Bueno & Amparo Cano. (2019) Contribution of Epithelial Plasticity to Therapy Resistance. Journal of Clinical Medicine 8:5, pages 676.
Crossref
Crossref
Snahlata Singh & Rumela Chakrabarti. (2019) Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells. Journal of Clinical Medicine 8:5, pages 642.
Crossref
Crossref
Yongmei Cui, Wenfeng Fang, Chaofeng Li, Kejing Tang, Jian Zhang, Yiyan Lei, Weiling He, Sui Peng, Ming Kuang, Hui Zhang, Lili Chen, Di Xu, Cuilan Tang, Wenhui Zhang, Yuxin Zhu, Wenting Jiang, Neng Jiang, Yu Sun, Yangshan Chen, Han Wang, Yingrong Lai, Shuhua Li, Qiong He, Jianwen Zhou, Yang Zhang, Millicent Lin, Honglei Chen, Chenzhi Zhou, Chunlin Wang, Jianhong Wang, Xuenong Zou, Liantang Wang & Zunfu Ke. (2019) Development and Validation of a Novel Signature to Predict Overall Survival in “Driver Gene–negative” Lung Adenocarcinoma (LUAD): Results of a Multicenter Study. Clinical Cancer Research 25:5, pages 1546-1556.
Crossref
Crossref
Chiara Nicolazzo, Angela Gradilone, Guido Carpino, Paola Gazzaniga & Cristina Raimondi. 2019. Cancer Immunosurveillance. Cancer Immunosurveillance
247
258
.
Seila Lorenzo-Herrero, Alejandro López-Soto, Christian Sordo-Bahamonde, Ana Gonzalez-Rodriguez, Massimo Vitale & Segundo Gonzalez. (2018) NK Cell-Based Immunotherapy in Cancer Metastasis. Cancers 11:1, pages 29.
Crossref
Crossref
David AG Skibinski. (2018) Noninvasive detection of PD-L1 on circulating tumor cells in patient blood samples. Future Oncology 14:13, pages 1237-1240.
Crossref
Crossref
Chiara Nicolazzo, Luciano Colangelo, Alessandro Corsi, Guido Carpino, Angela Gradilone, Chiara Sonato, Cristina Raimondi, Eugenio Gaudio, Paola Gazzaniga & Walter Gianni. (2018) Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma. Analytical Cellular Pathology 2018, pages 1-4.
Crossref
Crossref
Chiara Nicolazzo, Cristina Raimondi, Flavia Loreni, Paola Gazzaniga & Angela Gradilone. (2017) Letter to the Editor: “Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy”. International Journal of Molecular Sciences 18:6, pages 1308.
Crossref
Crossref